Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Azacitidine”

678 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 678 results

Testing effectiveness (Phase 2)Study completedNCT04266795
What this trial is testing

Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia (AML)
Takeda 164
Not applicableStudy completedNCT02891551
What this trial is testing

An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute
Celgene 209
Testing effectiveness (Phase 2)Active Not RecruitingNCT01305499
What this trial is testing

A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Hetty Carraway 52
Testing effectiveness (Phase 2)Study completedNCT03701295
What this trial is testing

Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement

Who this might be right for
Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLLeukemia CutisRecurrent Acute Myeloid Leukemia+1 more
National Cancer Institute (NCI) 1
Early research (Phase 1)Ended earlyNCT00901537
What this trial is testing

Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Loma Linda University 8
Early research (Phase 1)Study completedNCT04887857
What this trial is testing

Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
Celgene 6
Early research (Phase 1)Study completedNCT01390311
What this trial is testing

Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Washington University School of Medicine 14
Early research (Phase 1)Study completedNCT00351975
What this trial is testing

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Who this might be right for
Accelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT00897130
What this trial is testing

5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)

Who this might be right for
Myelodysplastic Syndrome
Università degli Studi di Brescia 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT01787487
What this trial is testing

Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiableMyelofibrosis Transformation in Essential ThrombocythemiaPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+1 more
M.D. Anderson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT03513484
What this trial is testing

Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2AFibroblast Growth Factor Basic Form MeasurementFLT3 Internal Tandem Duplication+2 more
Northwestern University 44
Not applicableUnknownNCT05772728
What this trial is testing

Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)

Who this might be right for
T Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07283900
What this trial is testing

Ascorbate in Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Prajwal Dhakal 38
Post-approval studies (Phase 4)Looking for participantsNCT07044687
What this trial is testing

Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India

Who this might be right for
Acute Myeloid Leukemia
AbbVie 100
Testing effectiveness (Phase 2)WithdrawnNCT05367401
What this trial is testing

Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS Participants

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Novartis Pharmaceuticals
Early research (Phase 1)Ended earlyNCT05155709
What this trial is testing

Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 14
Early research (Phase 1)Ended earlyNCT01636609
What this trial is testing

Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00005934
What this trial is testing

5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia

Who this might be right for
Beta Thalassemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Testing effectiveness (Phase 2)Looking for participantsNCT06827899
What this trial is testing

Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Xiamen University 66
Testing effectiveness (Phase 2)Ended earlyNCT02942758
What this trial is testing

Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML

Who this might be right for
Acute Myeloid Leukemia
University Hospital Regensburg 10
Load More Results
121